Intel's Surge Masks Persistent Constraints and Foundry Losses

What happened

Intel shares have rallied 281.8% year-to-date to near $141, driven by optimism around its 18A node and the narrative of packaging the future of American chips. However, the latest filings reveal that Intel expects supply constraints to persist throughout 2026 and has not secured any significant external foundry customers. Intel Foundry remains deeply unprofitable, with a $2.4 billion quarterly operating loss, and external revenue is mostly from Altera's reclassification rather than new third-party wins. The stock's valuation, at over 40x EV/EBITDA and negative EPS, prices in a rapid inflection that the company's own disclosures contradict. The disconnect between the market's optimism and Intel's disclosed operating reality suggests the rally is built on narrative rather than fundamentals.

Implication

Intel's 281.8% YTD surge reflects market hopes for a quick foundry turnaround and 18A ramp, but filings show supply constraints through 2026 and zero significant external foundry customers. Foundry losses remain steep at $2.4B per quarter, and external revenue is negligible beyond Altera reclassification. Valuation at 40x EV/EBITDA with negative EPS provides no margin of safety. The thesis hinges on visible de-risking by Q4 2026, but current evidence points to continued constraints and no external validation. Without concrete unit volume growth and a named foundry customer, the stock is likely to de-rate toward $75–$105.

Thesis delta

The rapid price appreciation to $141 increases the risk of disappointment, as the fundamental timeline for foundry validation and supply relief extends beyond market expectations. The report's previous $110 base-case now appears generous; the market is pricing in the bull case without the evidence. No new information in the news article alters the bearish thesis that Intel's turnaround will take longer and face more execution risk than priced.